Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
about
Prenatal androgenization of female mice programs an increase in firing activity of gonadotropin-releasing hormone (GnRH) neurons that is reversed by metformin treatment in adulthoodLarge effects on body mass index and insulin resistance of fat mass and obesity associated gene (FTO) variants in patients with polycystic ovary syndrome (PCOS).Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome.Enhanced ovarian folliclular development by metformin does not correlate with pregnancy rate: a randomized trial.The Role of Metformin in Metabolic Disturbances during Pregnancy: Polycystic Ovary Syndrome and Gestational Diabetes Mellitus.Liver Injury Indicating Fatty Liver but Not Serologic NASH Marker Improves under Metformin Treatment in Polycystic Ovary Syndrome.The role of anti-Mullerian hormone and inhibin B in the assessment of metformin therapy in women with polycystic ovarian syndromeImpact of Treatment with Metformin on Adipocytokines in Patients with Polycystic Ovary Syndrome: A Meta-AnalysisMetformin - For the dermatologist.Effects of insulin-sensitizing agents and insulin resistance in women with polycystic ovary syndromeInsulin and hyperandrogenism in women with polycystic ovary syndrome.Targeting insulin sensitivity in the treatment of polycystic ovary syndrome.Therapeutic effects of metformin and clomiphene in combination with lifestyle intervention on infertility in women with obese polycystic ovary syndrome.Use of metformin in the treatment of polycystic ovary syndrome.Polycystic ovary syndrome: an overview.Focus on metabolic and nutritional correlates of polycystic ovary syndrome and update on nutritional management of these critical phenomena.Metformin versus laparoscopic ovarian drilling in clomiphene- and insulin-resistant women with polycystic ovary syndrome.Debates Regarding Lean Patients with Polycystic Ovary Syndrome: A Narrative Review.Clinical outcome of various metformin treatments for women with polycystic ovary syndrome.Insulin resistance in nonobese Japanese women with polycystic ovary syndrome is associated with poorer glucose tolerance, delayed insulin secretion, and enhanced insulin response.Metabolic and androgen profile in underweight women with polycystic ovary syndrome.Randomized controlled trial of different doses of metformin for ovulation induction in infertile women with polycystic ovary syndrome.Effect of metformin and spironolactone therapy on OGTT in patients with polycystic ovarian syndrome - a retrospective analysis.Therapeutic effects of metformin and laparoscopic ovarian drilling in treatment of clomiphene and insulin-resistant polycystic ovary syndromePolycystic Ovary Syndrome: Implication for Drug Metabolism on Assisted Reproductive Techniques-A Literature Review
P2860
Q30428511-BB3C3388-0126-450A-AAFC-704EFB7F06CDQ33525709-57DDF798-092F-4CB3-A94F-E7E0E780A584Q34011105-47465B69-2FD8-4E31-AA66-590B32D99717Q34661716-6BFA35F5-7ED1-41E9-A4FA-214E96842798Q35100131-4EF9240D-2CC3-4246-B518-0C23C86CBFCCQ35250192-827A5620-6C34-48A7-B75E-6A1DC4BB50ECQ35621711-8F1BD8A5-4AFC-400B-A114-482A06CA8130Q35810003-C88F1F53-0F72-47A1-AFDE-D0C92557FB5BQ36651435-ED2EABA9-1C0C-44B0-A74B-D40762EE2448Q37022386-3DEFB408-1465-42C2-8FB5-A1398C1BE087Q37355746-DBA82336-9413-496A-9CB3-1653089BA0B0Q37570577-2AF82178-0BBD-4175-824D-66BE71425EBFQ37723627-D26719B4-A9E8-4C0B-BDDB-6163C0550F9BQ37769526-B99C31C6-C0FA-49BB-A039-ACA6E836220FQ37886072-833C27A7-AC2A-470B-AB55-D42799CE0A02Q38247074-69BAEA52-E440-41B5-9001-6E29C4709123Q43247814-365C553E-B2E8-463F-8760-512CB4D8FAA2Q46631027-495CB84A-0428-4959-97BB-DDF9BE1FD4A2Q47094213-A1AB51F6-2A40-4373-A932-C8C0E78EB723Q47118292-CCB8ABBB-D012-4F78-99FF-B8DAC0CA5B9CQ47348011-F253A257-73CD-4A93-A123-DCCA475688F9Q51037574-7DFFB06E-CB2B-41F2-877B-DF652A3E2EC3Q51358591-8E50DA18-9545-4A46-9159-5F5A09C13123Q56507893-4F274C24-6BE3-4AA9-A0DA-58BC3D377528Q57473711-11BA6FA6-EF68-44E7-A270-C7CCFE79B383
P2860
Metformin improves polycystic ovary syndrome symptoms irrespective of pre-treatment insulin resistance.
description
2007 nî lūn-bûn
@nan
2007 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Metformin improves polycystic ...... -treatment insulin resistance.
@ast
Metformin improves polycystic ...... -treatment insulin resistance.
@en
Metformin improves polycystic ...... -treatment insulin resistance.
@nl
type
label
Metformin improves polycystic ...... -treatment insulin resistance.
@ast
Metformin improves polycystic ...... -treatment insulin resistance.
@en
Metformin improves polycystic ...... -treatment insulin resistance.
@nl
prefLabel
Metformin improves polycystic ...... -treatment insulin resistance.
@ast
Metformin improves polycystic ...... -treatment insulin resistance.
@en
Metformin improves polycystic ...... -treatment insulin resistance.
@nl
P2093
P921
P356
P1476
Metformin improves polycystic ...... -treatment insulin resistance.
@en
P2093
Harald Lahner
Klaus Mann
Lars C Moeller
Markus Schmidt
Onno E Janssen
Rainer Kimmig
Sigrid Elsenbruch
Susanne Hahn
Susanne Tan
Sven Benson
P304
P356
10.1530/EJE-07-0294
P577
2007-11-01T00:00:00Z